← Back to patent-cliff list
盐酸羟甲唑啉/盐酸丁卡因
Tier C — Watch / tradeOxymetazoline Hydrochloride/Tetracaine Hydrochloride
St. Renatus Llc
Originator
2016
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：ADRA1A
Brand：Kovanaze
Indications (approved)：麻醉
Regional status
US
批准上市
2016-06-29
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Oxymetazoline Hydrochloride/Tetracaine Hydrochloride?
Approved indications include: 麻醉.
When does the Oxymetazoline Hydrochloride/Tetracaine Hydrochloride patent expire?
No public expiry year is available for Oxymetazoline Hydrochloride/Tetracaine Hydrochloride yet; this page updates once verified.
How do I get a quote for Oxymetazoline Hydrochloride/Tetracaine Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24